Overview
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute and a pioneer in cancer immunotherapy. He is known for developing life-saving CAR-T and Tumor-Infiltrating Lymphocyte (TIL) therapies.
Biography
Dr. Steven A. Rosenberg is the Chief of Surgery at the National Cancer Institute and a pioneer in cancer immunotherapy. He is known for developing life-saving CAR-T and Tumor-Infiltrating Lymphocyte (TIL) therapies.
Research Impact
5 Publications
0 Total Citations
Published In
ScienceN Engl J MedJ Clin Invest
Key Publications
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.
Adoptive cell transfer as personalized immunotherapy for human cancer.
Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer.
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.
Areas of Expertise
Medical Specialties
Media Archive
Related Specialists
View AllAre you Steven A. Rosenberg?
Claim your MDRPedia profile to unlock analytics, manage your digital legacy, and receive your verified badge.